Related Experiment Videos
[Need of updating hepatological nosology]
A Lonardo1, A Grisendi, M Pulvirenti
1Divisione di Medicina Generale I, Ospedale civile, Modena.
Insights
The current classification of chronic liver disease (CLD) is inadequate for complex cases like liver cirrhosis with diabetes or autoimmune diseases. Future understanding of metabolic and immunologic issues in CLD will likely reshape its nosological classification.
Area of Science:
- Hepatology and Immunology
- Metabolic Disorders
- Disease Classification
Background:
- Current nosological classification of chronic liver disease (CLD) based on histopathology is insufficient for complex clinical presentations.
- Clinical challenges include associations like liver cirrhosis-diabetes mellitus and autoimmune diseases-primary biliary cirrhosis (PBC).
- The concept of PBC as a systemic disease and multiorgan involvement in chronic active hepatitis highlight classification limitations.
Discussion:
- The limitations of histopathology-based CLD classification are evident in managing complex comorbidities.
- Understanding the systemic nature of diseases like PBC requires a broader diagnostic framework.
- Multiorgan involvement in chronic active hepatitis necessitates a more integrated approach to CLD.
Key Insights:
- The existing classification of chronic liver disease (CLD) fails to adequately address complex clinical scenarios.
- Associations between CLD, metabolic disorders (e.g., diabetes), and autoimmune conditions (e.g., PBC) challenge current nosology.
- The systemic nature and multiorgan impact of CLD underscore the need for a revised classification system.
Outlook:
- A revised nosological framework for CLD is anticipated.
- Future classification will likely integrate a deeper understanding of metabolic derangements associated with CLD.
- Advances in understanding immunologic dysregulation in CLD will be crucial for redefining disease categories.
Abstract:
The nosological classification of chronic liver disease (CLD) seems to be unsatisfactory when clinical problems are faced such as the liver cirrhosis-diabetes mellitus and the autoimmune diseases-primary biliary cirrhosis (PBC) associations; the concept of PBC as a systemic disease; the multiorgan involvement of chronic active hepatitis. Accordingly, the Authors hypothesize that the present histopathological-based nosology of CLD will be modified as a result of a better understanding of the varied metabolic and immunologic derangements induced by CLD.